| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Afatinib After Progression on Osimertinib in EGFR-Mutated Non-Small Cell Lung Cancer
|
Aredo, Jacqueline V
|
|
|
30 |
C |
p.
|
article
|
| 2 |
A retrospective chart review of management strategies for lichenoid eruptions associated with immune-checkpoint inhibitor therapy from a single institution
|
Masterson, Wylie M.
|
|
|
30 |
C |
p.
|
article
|
| 3 |
Association of smoking with anal high-risk HPV infection and histologically confirmed anal high-grade squamous intraepithelial lesions among a clinic-based population in Puerto Rico
|
Keller, Kandyce
|
|
|
30 |
C |
p.
|
article
|
| 4 |
A systematic update to circulating extracellular vesicles proteome; transcriptome and small RNA-ome as glioma diagnostic, prognostic and treatment-response biomarkers
|
Nikoobakht, Mehdi
|
|
|
30 |
C |
p.
|
article
|
| 5 |
Autophagy Modulation and Cancer Combination Therapy: A Smart Approach in Cancer Therapy
|
Salimi-Jeda, Ali
|
|
|
30 |
C |
p.
|
article
|
| 6 |
Druggable genetic targets in endometrial cancer✰,✰✰
|
Lehrer, Steven
|
|
|
30 |
C |
p.
|
article
|
| 7 |
Multiple myeloma in Lebanon: Trend analysis, 10-year projections and comparisons to other countries
|
Jalloul, Mohammad
|
|
|
30 |
C |
p.
|
article
|
| 8 |
Phase I Trial of Definitive Concurrent Chemoradiotherapy and Trametinib for KRAS-Mutated Non-Small Cell Lung Cancer
|
Lin, Steven H
|
|
|
30 |
C |
p.
|
article
|
| 9 |
Pregnancy induced hyperplasia of residual breast tissue following risk reducing contralateral mastectomy - simply interesting or a clinically important observation
|
Pitiyarachchi, Omali
|
|
|
30 |
C |
p.
|
article
|
| 10 |
Presenting features and overall survival of chondrosarcoma of the pelvis
|
Brown, Jeffrey Mark
|
|
|
30 |
C |
p.
|
article
|
| 11 |
Risk for relapse and death after adjuvant chemotherapy associated with SNPs in patients with breast cancer - A retrospective study.
|
Oliva, Delmy
|
|
|
30 |
C |
p.
|
article
|
| 12 |
Sellar plasmacytoma with massive bleeding during surgery
|
Lee, Dong Hoon
|
|
|
30 |
C |
p.
|
article
|
| 13 |
Subclonal landscape of cancer drives resistance to immune therapy
|
Craig, Daniel J.
|
|
|
30 |
C |
p.
|
article
|
| 14 |
Survival of clinical stage III NSCLC according to therapeutic strategy: Relevance of the tumor board decision in the era of immunotherapy
|
Benet, Justin
|
|
|
30 |
C |
p.
|
article
|
| 15 |
The effects of tislelizumab plus chemotherapy as first-line treatment on health-related quality of life of patients with advanced squamous non-small cell lung cancer: Results from a phase 3 randomized clinical trial
|
Wang, J
|
|
|
30 |
C |
p.
|
article
|
| 16 |
Vorinostat enhances the therapeutic potential of Erlotinib via MAPK in lung cancer cells
|
Alqosaibi, Amany I
|
|
|
30 |
C |
p.
|
article
|
Journal description